drugset / Trial / NCT02965495

Clinical Trial of YYD302 for Treatment of Osteoarthritis of the Knee

NCT02965495 ↗

Phase 1/2 Completed 30 enrolled Yooyoung Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a multicenter, randomized, double-blinded, parallel, placebo-controlled, phase I/IIa clinical trial of YYD302 for treatment of osteoarthritis of the knee.

Timeline

Start
2016-11
Primary completion
2017-09
Completion
2017-09

Drugs

EvaluationDrugModalityDoseRoute
Subject YYD302 Other / unclassified 2 ml Other
Subject YYD302 Other / unclassified 3 ml Other

Indications